Log In
Print
BCIQ
Print
Print this Print this
 

ONX 0805, SB1578

  Manage Alerts
Collapse Summary General Information
Company S*BIO Pte. Ltd.
DescriptionOral Janus kinase-2 (JAK-2) inhibitor
Molecular Target Janus kinase-2 (JAK-2)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today